This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: University of Illinois. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Viswanathan Natarajan: Innovator in Pulmonary Disease Treatment
Introduction
Viswanathan Natarajan is a notable inventor based in Frankfort, IL (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of pulmonary diseases. His innovative approach has led to the development of a unique method that addresses critical health issues.
Latest Patents
Natarajan holds a patent for a "Method of preventing or treating a pulmonary disease or condition." This patent includes a pharmaceutical composition for aerosol administration and a method of preventing or treating a pulmonary disease or condition in a subject using a SphK1 inhibitor. This invention showcases his commitment to advancing medical science and improving patient outcomes.
Career Highlights
Viswanathan Natarajan is affiliated with the University of Illinois, where he continues to engage in research and development. His work is characterized by a focus on innovative solutions that address complex health challenges. With 1 patent to his name, he exemplifies the spirit of innovation in the medical field.
Collaborations
Natarajan has collaborated with esteemed colleagues, including Anantha Harijith and Roberto F Machado. These partnerships highlight the collaborative nature of research and the importance of teamwork in achieving groundbreaking results.
Conclusion
Viswanathan Natarajan's contributions to the treatment of pulmonary diseases through his innovative patent reflect his dedication to improving healthcare. His work at the University of Illinois and collaborations with fellow researchers underscore the importance of innovation in medicine.